Plasma and amniotic fluid PPARγ is involved in the lipid metabolism of maternal–fetal interface cells

References

• Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011;94(6 Suppl):1896S–902S.
   PubMed Web of Science ®Google Scholar
• Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy – are these the cause of the problem? Best Pract Res Clin Endocrinol Metab. 2010;24(4):515–525.
   PubMed Web of Science ®Google Scholar
• Scifres CM, Catov JM, Simhan H. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia. J Clin Endocrinol Metab. 2012;97(3):E349–E356.
   PubMed Web of Science ®Google Scholar
• Aires MB, Dos Santos AC. Effects of maternal diabetes on trophoblast cells. World J Diabetes. 2015;6(2):338–344.
   PubMed Web of Science ®Google Scholar
• Liu B, Xu Y, Voss C, et al. Altered protein expression in gestational diabetes mellitus placentas provides insight into insulin resistance and coagulation/fibrinolysis pathways. PLoS One. 2012;7(9):e44701.
   PubMed Web of Science ®Google Scholar
• Pavlou MP, Diamandis EP. The cancer cell secretome: a good source for discovering biomarkers? J Proteom. 2010;73(10):1896–1906.
   PubMed Web of Science ®Google Scholar
• Makridakis M, Vlahou A. Secretome proteomics for discovery of cancer biomarkers. J Proteom. 2010;73(12):2291–2305.
   PubMed Web of Science ®Google Scholar
• Dowling P, Hughes DJ, Larkin AM, et al. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer. Clin Chim Acta Int J Clin Chem. 2015;441:133–141.
   PubMed Web of Science ®Google Scholar
• Antelmann H, Tjalsma H, Voigt B, et al. A proteomic view on genome-based signal peptide predictions. Genome Res. 2001;11(9):1484–1502.
   PubMed Web of Science ®Google Scholar
• Fournier T, Tsatsaris V, Handschuh K, et al. PPARs and the placenta. Placenta. 2007;28(2–3):65–76.
   PubMed Web of Science ®Google Scholar
• Arck P, Toth B, Pestka A, et al. Nuclear receptors of the peroxisome proliferator-activated receptor (PPAR) family in gestational diabetes: from animal models to clinical trials. Biol Reprod. 2010;83(2):168–176.
   PubMed Web of Science ®Google Scholar
• McCarthy FP, Delany AC, Kenny LC, et al. PPARγ – a possible drug target for complicated pregnancies. Br J Pharmacol. 2013;168(5):1074–1085.
   PubMed Web of Science ®Google Scholar
• Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454(7203):470–477.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79(7):1147–1156.
   PubMed Web of Science ®Google Scholar
• Franks PW, Jablonski KA, Delahanty L, et al. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia. 2007;50(12):2451–2460.
   PubMed Web of Science ®Google Scholar
• Wang LH, Yang XY, Zhang X, et al. Transcriptional inactivation of STAT3 by PPAR gamma suppresses IL-6-responsive multiple myeloma cells. Immunity. 2004;20(2):205–218.
   PubMed Web of Science ®Google Scholar
• Tarrade A, Lai Kuen R, Malassiné A, et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest. 2001;81(9):1199–1211.
   PubMed Web of Science ®Google Scholar
• Tarrade A, Schoonjans K, Guibourdenche J, et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology. 2001;142(10):4504–4514.
   PubMed Web of Science ®Google Scholar
• Peeters LL, Vigne JL, Tee MK, et al. PPAR gamma represses VEGF expression in human endometrial cells: implications for uterine angiogenesis. Angiogenesis. 2005;8(4):373–379.
   PubMedGoogle Scholar
• Wice B, Menton D, Geuze H, et al. Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp Cell Res. 1990;186(2):306–316.
   PubMed Web of Science ®Google Scholar
• Ringler GE, Strauss JF, 3rd. In vitro systems for the study of human placental endocrine function. Endocr Rev. 1990;11(1):105–123.
   Google Scholar
• Al-Nasiry S, Spitz B, Hanssens M, et al. Differential effects of inducers of syncytialization and apoptosis on BeWo and JEG-3 choriocarcinoma cells. Hum Reprod. 2006;21(1):193–201.
   PubMed Web of Science ®Google Scholar
• Zhu H, Hou CC, Luo LF, et al. Endometrial stromal cells and decidualized stromal cells: origins, transformation and functions. Gene. 2014;551(1):1–14.
   PubMed Web of Science ®Google Scholar
• Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Group of Pregnancy with Diabetes Mellitus, Chinese Society of Perinatal Medicine, Chinese Medical Association, Obstetrics Subgroup Chinese Society of Obstetrics and Gynecology Chinese Medical Association, et al. Diagnosis and therapy guideline of pregnancy with diabetes mellitus. Zhonghua fu chan ke zhi. 2014;49(8):561–569.
   PubMedGoogle Scholar
• Davies SS, Pontsler AV, Marathe GK, et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem. 2001;276(19):16015–16023.
   PubMed Web of Science ®Google Scholar
• Rodie VA, Young A, Jordan F, et al. Human placental peroxisome proliferator-activated receptor delta and gamma expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig. 2005;12(5):320–329.
   PubMedGoogle Scholar
• Schaiff WT, Carlson MG, Smith SD, et al. Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab. 2000;85(10):3874–3881.
   PubMed Web of Science ®Google Scholar
• Waite LL, Person EC, Zhou Y, et al. Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab. 2000;85(10):3808–3814.
   PubMed Web of Science ®Google Scholar
• Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30(Suppl 2):S120–S126.
   PubMedGoogle Scholar
• Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev. 2008;75(6):1054–1062.
   PubMed Web of Science ®Google Scholar
• Rizzo M, Berneis K, Altinova AE, et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med. 2008;25(12):1406–1411.
   PubMed Web of Science ®Google Scholar
• Pavan L, Tarrade A, Hermouet A, et al. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. Carcinogenesis. 2003;24(8):1325–1336.
   PubMed Web of Science ®Google Scholar
• Wang L, Yang X, Wang W. Isolation and identification of human endometrial stromal stem cells. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013;42(3):311–318.
   PubMedGoogle Scholar
• Corazzin M, Bovolenta S, Saccà E, et al. Effect of linseed addition on the expression of some lipid metabolism genes in the adipose tissue of young Italian Simmental and Holstein bulls. J Anim Sci. 2013;91(1):405–412.
   PubMed Web of Science ®Google Scholar
• Baumann MU, Schneider H, Malek A, et al. Regulation of human trophoblast GLUT1 glucose transporter by insulin-like growth factor I (IGF-I). PLoS One. 2014;9(8):e106037.
   PubMed Web of Science ®Google Scholar
• Augustin R. The protein family of glucose transport facilitators: it’s not only about glucose after all. IUBMB Life. 2010;62(5):315–333.
   PubMed Web of Science ®Google Scholar